Apotex Health Raises Fiscal 2027 Revenue Growth Outlook to 9%–10%
Apotex Health raised its fiscal 2027 revenue growth outlook to 9%–10% after new drug launches and higher sales drove fiscal second-quarter earnings higher.
By Adriano MarcheseApotex Health increased its full-year outlook after new drug launches and higher sales drove fiscal second-quarter earnings higher.The Canadian pharmaceutical company said Thursday that it now expects revenue to grow between 9% and 10% in fiscal 2027, up from a previous expectati…